Senators revive bill targeting expanded methadone access
Impact on your practice
While not directly targeting therapists, this expands treatment access for substance use disorders, a population therapists frequently treat. It may increase referral pathways and collaborative care opportunities for LCSWs and LPCs involved in OUD treatment.
Key facts
Bipartisan bill would allow board-certified physicians to prescribe methadone outside of specialized opioid treatment programs
Would enable pharmacies to dispense methadone for OUD, reducing patient travel burden (currently 4.5x farther to reach treatment programs vs. pharmacies)
Expands HHS authority to designate additional licensed providers without requiring new legislation
Supported by 50+ organizations including AMA, ASAM, and major health systems
Policy changes drive denial patterns
Therapy Companion tracks both: the policy shifts on this page and the denial patterns hitting your claims.
Related policy changes
APA concerned about far-reaching consequences from Supreme Court decision regarding therapy as ‘free speech’
This Supreme Court doctrine creates legal ambiguity around the state's power to regulate what licensed therapists do and say. It threatens the foundational regulatory model that protects both public safety and therapist professional standing, and could be weaponized to challenge licensure requirements themselves.
Opinion: Patients seeking mental health treatment are not commodities
This opinion identifies a practice management issue affecting therapists' professional autonomy and income—restrictive covenants in employment contracts that penalize leaving practices. This is directly relevant to solo practitioners considering employment or practice group involvement.
Maryland expands pharmacist scope to include opioid use disorder treatment
This expansion of pharmacist authority in OUD treatment affects therapists' competitive positioning and collaborative care model design. Therapists should understand that pharmacists now have direct prescribing authority for buprenorphine in Maryland, potentially reducing reliance on physicians and creating new inter-professional boundaries. For practices treating OUD, this changes referral patterns and may increase need for clear role definition in collaborative teams.
VA Mental Health Outreach and Engagement Act
This VA-focused bill won't directly change private practice operations, but improved VA mental health infrastructure could shift referral patterns and create contracting opportunities for private therapists. Practitioners serving veterans should monitor for new VA partnership models.